Innate Pharma SA Cash Advances And Loans From Related Parties
Innate Pharma SA (IPHYF) reported Cash Advances And Loans From Related Parties of EUR 2.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:CashAdvancesAndLoansFromRelatedParties · last filed 2026-04-01
| Period end | Cash Advances And Loans From Related Parties 6 month | Cash Advances And Loans From Related Parties 12 month |
|---|---|---|
| 2025-12-31 | 2.00M EUR 20-F · filed 2026-04-01 | |
| 2024-12-31 | 2.64M EUR 20-F · filed 2025-04-30 | |
| 2024-06-30 | 1.66M EUR 6-K · filed 2024-09-12 | |
| 2023-12-31 | 4.72M EUR 20-F · filed 2024-04-04 | |
| 2023-06-30 | 3.28M EUR 6-K · filed 2023-09-14 | |
| 2022-12-31 | 54.77M EUR 20-F · filed 2023-04-06 | |
| 2022-06-30 | 48.74M EUR 6-K · filed 2022-09-15 | |
| 2021-12-31 | 5.32M EUR 20-F · filed 2022-04-04 | |
| 2021-06-30 | 1.71M EUR 6-K · filed 2021-09-15 | |
| 2020-12-31 | 57.78M EUR 20-F · filed 2021-04-27 | |
| 2019-12-31 | 118.63M EUR 20-F · filed 2020-04-24 |